Breaking News Instant updates and real-time market news.

TSLA

Tesla

$352.08

-18.12 (-4.89%)

17:10
08/09/18
08/09
17:10
08/09/18
17:10

Tesla board to meet with advisors next week over going-private talks, CNBC says

Tesla's board of directors intends to meet with financial advisors next week to formalize a process to explore CEO Elon Musk's proposal to take the car maker private, CNBC reports, citing people familiar with the matter. Musk said on Twitter this week that he hopes to take the company private, the report notes. The board will likely tell the chairman and CEO to recuse himself as the car maker prepares to review his proposal, the report says. The board has informed Musk that he needs his own set of advisors, the report notes. Reference Link

  • 29

    Oct

TSLA Tesla
$352.08

-18.12 (-4.89%)

08/08/18
MSCO
08/08/18
NO CHANGE
Target $291
MSCO
Equal Weight
Musk may want to take Tesla private, but Morgan Stanley questions feasibility
While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questions the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." The benefits of being private are outweighed by the risks of added financial leverage, which could be even more strategically limiting, added Jonas, who keeps an Equal Weight rating on Tesla shares with a price target of $291.
08/08/18
BARD
08/08/18
NO CHANGE
Target $411
BARD
Outperform
Tesla $420 buyout price mentioned by Musk too low, says Baird
Baird analyst Ben Kallo believes the Tesla buyout price of $420 mentioned by Elon Musk is too low. He expects the shares to trade above that mark as investors will demand a higher premium, which will coincide with short covering. Kallo reiterated his Outperform rating and $411 price target on Tesla shares.
08/08/18
RBCM
08/08/18
NO CHANGE
Target $110
RBCM
Outperform
RBC Capital revisits idea of Celgene going private after Tesla proposal
Following yesterday's news that Tesla (TSLA) CEO Elon Musk would like to see his company go private, RBC analyst Brian Abrahams revisited his prior analysis of whether Celgene (CELG) should go private in order to better capture the medium-term value of future Revlimid cash flows not being appreciated by public markets and avoid volatility as it transitions to a post-Revlimid business model. Though acknowledging that the two companies are in completely different industries, he thinks the example of Musk shows that performing such a transaction on a large company "may not be completely unrealistic," Abrahams said. Such an LBO, or perhaps more likely an acquisition by a larger pharmaceutical company, could possibly help capture more value from Celgene's commercial and pipeline products, concludes Abrahams, who has an Outperform rating and $110 price target on Celgene shares.
08/08/18
08/08/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. REACTIONS TO TESLA'S TALK OF GOING PRIVATE: Jefferies analyst Philippe Houchois raised his price target for Tesla (TSLA) to $360 from $250 after CEO Elon Musk suggested taking the company private. Going private "feels like the right thing to do," Houchois said. "Distraction or not, the move feels right even if Musk is downplaying how supportive public markets have been," the analyst adds. However, with Tesla unable to take on more debt, Houchois wondered who may fund the potential deal and end up as a new large shareholder. While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questioned the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." MORGAN STANLEY SAYS SOUTHWEST A GOOD FIT FOR BERKSHIRE: Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan. He analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation. Pan has an Overweight rating and $67 price target on Southwest shares. BARCLAYS POSITIVE ON SNAP GUIDANCE CHANGE: Barclays analyst Ross Sandler views Snap's (SNAP) Q2 results as a "mixed bag," with daily active users 2M below his estimate and revenue $20M above his estimate. More importantly, the change in approach towards guidance is "very welcomed and should help to reduce some of the volatility going forward," Sandler said. He believes this is a "big positive for long-term holders looking to get involved." The analyst kept an Overweight rating on Snap with a $16 price target. WAINWRIGHT SAYS INSMED LIKELY TO BE ACQUIRED: H.C. Wainwright analyst Andrew Fein raised his price target for Insmed (INSM) to $43 from $35 following the 12-2 FDA panel vote in favor of ALIS in refractory nontuberculous mycobacterial patients. Insmed is now likely to be acquired as ALIS "fits well within the pipeline of a number of larger companies," Fein said.

TODAY'S FREE FLY STORIES

WRD

WildHorse Resource

$21.31

-0.12 (-0.56%)

17:05
09/20/18
09/20
17:05
09/20/18
17:05
Hot Stocks
WildHorse Resource adds acreage in Burleson, Brazos, Lee, Washington Counties »

WildHorse Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

, RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

17:02
09/20/18
09/20
17:02
09/20/18
17:02
Periodicals
Shell in discussions to sell $1.3B in Gulf Coast assets, Bloomberg says »

Royal Dutch Shell (RDS.A)…

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

APC

Anadarko

$63.86

-0.88 (-1.36%)

EQNR

Equinor

$26.45

-0.09 (-0.34%)

CVX

Chevron

$119.46

-0.04 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 26

    Sep

MU

Micron

$46.06

1.01 (2.24%)

17:02
09/20/18
09/20
17:02
09/20/18
17:02
Earnings
Micron sees Q1 EPS $2.95, +/- 7c, consensus $2.73 »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

AL

Air Lease

$45.80

0.09 (0.20%)

, EADSY

Airbus

$0.00

(0.00%)

17:02
09/20/18
09/20
17:02
09/20/18
17:02
Hot Stocks
Air Lease announces delivery of Airbus A320-200neo aircraft with SKY »

Air Lease (AL) announced…

AL

Air Lease

$45.80

0.09 (0.20%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

MU

Micron

$46.06

1.01 (2.24%)

16:52
09/20/18
09/20
16:52
09/20/18
16:52
Hot Stocks
Micron says it achieved record revenue in FY18 »

Says expects 1ynm sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

PMBC

Pacific Mercantile Bancorp

$9.75

0.025 (0.26%)

16:50
09/20/18
09/20
16:50
09/20/18
16:50
Hot Stocks
Breaking Hot Stocks news story on Pacific Mercantile Bancorp »

EJF Capital reports 7.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MU

Micron

$46.06

1.01 (2.24%)

16:46
09/20/18
09/20
16:46
09/20/18
16:46
Hot Stocks
Breaking Hot Stocks news story on Micron »

Micron up 5.7% to $48.69…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

16:45
09/20/18
09/20
16:45
09/20/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Blue Hills Bancorp »

Blue Hills Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$24.82

0.17 (0.69%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Teva initiated  »

Teva assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

CRSP

Crispr Therapeutics

$48.90

-3 (-5.78%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Crispr Therapeutics initiated  »

Crispr Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Sep

NTLA

Intellia Therapeutics

$31.50

-0.48 (-1.50%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Intellia Therapeutics initiated  »

Intellia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

EDIT

Editas Medicine

$32.55

-0.64 (-1.93%)

16:43
09/20/18
09/20
16:43
09/20/18
16:43
Initiation
Editas Medicine initiated  »

Editas Medicine initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMC

Western Asset Mortgage

$11.30

0.055 (0.49%)

16:42
09/20/18
09/20
16:42
09/20/18
16:42
Syndicate
Western Asset Mortgage 6.5M share Spot Secondary; price range $10.85-$11.10 »

Morgan Stanley,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$20.00

0.4 (2.04%)

16:41
09/20/18
09/20
16:41
09/20/18
16:41
Initiation
Vanda Pharmaceuticals initiated  »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

WYNN

Wynn Resorts

$137.32

1.64 (1.21%)

16:41
09/20/18
09/20
16:41
09/20/18
16:41
Hot Stocks
Breaking Hot Stocks news story on Wynn Resorts »

Lone Pine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

, RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

16:41
09/20/18
09/20
16:41
09/20/18
16:41
Periodicals
Shell in discussions to sell $1.3B in Gulf Coast assets, Bloomberg says »

Royal Dutch Shell is in…

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPVG

TriplePoint Venture

$12.97

-0.01 (-0.08%)

16:39
09/20/18
09/20
16:39
09/20/18
16:39
Initiation
TriplePoint Venture initiated  »

TriplePoint Venture…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMPH

KemPharm

$4.70

-0.25 (-5.05%)

16:38
09/20/18
09/20
16:38
09/20/18
16:38
Initiation
KemPharm initiated  »

KemPharm assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLL

Ball Corp.

$44.39

0.15 (0.34%)

16:35
09/20/18
09/20
16:35
09/20/18
16:35
Hot Stocks
Ball Corp. CFO Scott Morrison sells over $1M in company shares »

Ball Corp. CFO Scott…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLIT

Harmonic

$5.20

0.15 (2.97%)

16:34
09/20/18
09/20
16:34
09/20/18
16:34
Initiation
Harmonic initiated  »

Harmonic initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

WMC

Western Asset Mortgage

$11.30

0.055 (0.49%)

16:34
09/20/18
09/20
16:34
09/20/18
16:34
Syndicate
Western Asset Mortgage files to sell 6.5M shares of common stock »

Morgan Stanley, BofA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,944.26

17.99 (0.93%)

, AAPL

Apple

$220.00

1.655 (0.76%)

16:33
09/20/18
09/20
16:33
09/20/18
16:33
Periodicals
Twitch appears to be blocked in China, Abacus reports »

Amazon's (AMZN)…

AMZN

Amazon.com

$1,944.26

17.99 (0.93%)

AAPL

Apple

$220.00

1.655 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WMC

Western Asset Mortgage

$11.30

0.055 (0.49%)

16:32
09/20/18
09/20
16:32
09/20/18
16:32
Syndicate
Western Asset Mortgage files to sell 6.5M shares of common stock »

Morgan Stanley, BofA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$70.79

0.8 (1.14%)

16:32
09/20/18
09/20
16:32
09/20/18
16:32
Hot Stocks
Merck receives positive CHMP opinion for DELSTRIGO and PILFETRO in E.U. »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 23

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

16:30
09/20/18
09/20
16:30
09/20/18
16:30
Options
Preliminary option volume of 24.2M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.